Find a COVID-19 Vaccine Near You
Questions? Call the Novel Coronavirus (COVID-19) Hotline: 1-888-364-3065 or Ask a Question
cachinglogo cache

ACIP Recommends First COVID-19 Vaccine for Use in U.S.; IAC Summarizes Guidance from December 11–12 Meeting

After holding nine formal meetings since June and hearing more than 70 presentations on COVID-19 vaccine, on December 12 the Advisory Committee on Immunization Practices voted to recommend the use of the Pfizer-BioNTech COVID-19 vaccine for persons 16 years of age and older in the United States. This historic vote followed issuance of the Food and Drug Administration’s Emergency Use Authorization (EUA) for the vaccine on December 11 [see story above].

The ACIP recommendations and additional guidance for the vaccine’s use became official when adopted by CDC and published as ACIP’s Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine—U.S, December 2020 in the Morbidity and Mortality Weekly Report (MMWR) Early Release issued on December 13.

While the MMWR publication should always be consulted for official guidance, additional highlights of ACIP’s clinical guidance discussed at the committee’s December 11–12 meeting are provided below:

ACIP also voted to add descriptive text and a link to current COVID-19 vaccine recommendations within the 2021 U.S. Adult and Child/Adolescent Immunization Schedules, which will be published in February.

CDC is updating the COVID-19 information on its web pages frequently, with several key resources listed below.

Related Links

Contact your local health department Contact your local health department Job Openings Looking for a job in public health? Job Openings Looking for a job in public health? Donate Donations help support local health departments Donate Donations help support local health departments
NYSACHO is incorporated as a not-for-profit, non-partisan charitable organization with 501(c)(3) tax exempt status.